Suchergebnisse
Suchergebnisse:
19. Apr. 2024 · Présidé par José Manuel Barroso et doté de 28 membres, le Conseil d’administration de Gavi exerce la direction suprême de l’Alliance du Vaccin. Présidente : José Manuel Barroso. Vice-président : Omar Abdi. Représentation. Membre du Conseil. Suppléant.
18. Apr. 2024 · In 2018, the Gavi Board conditionally approved support for the multivalent conjugate vaccine which protects against meningococcal meningitis A, C and W. However, it may be several years before the appropriate products are available and it is therefore essential that more countries introduce the existing meningitis A vaccine.
18. Apr. 2024 · By the end of 2019, Gavi support had helped countries immunise more than 215 million children across 60 lower-income countries against pneumococcal disease. In 2019, for the first time, pneumococcal vaccine coverage in Gavi-supported countries was higher than the worldwide average: 49% in 2019, up from 37% in 2015 and above the global average ...
24. Apr. 2024 · Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningococcal and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation, above all the zero-dose children who have not received even a single vaccine shot. The Vaccine Alliance employs ...
24. Apr. 2024 · France to co-host with African Union and Gavi the launch of the African Vaccine Manufacturing Accelerator (AVMA) and Gavi’s Investment Opportunity for 2026–2030. Read more. 19 March 2024.
18. Apr. 2024 · Dr Derrick Sim is Managing Director of Vaccine Markets & Health Security. In this role, Derrick leads Gavi’s Market Shaping team, ensuring healthy markets for vaccines and other immunisation products. He also leads the Health Security team, which builds on the Vaccine Alliance’s experience and learnings from responses to outbreaks and the ...
18. Apr. 2024 · Gavi began supporting pentavalent vaccine in 2001. The goal was to boost the low uptake of Hib and hepB vaccines by making them part of routine immunisation programmes in low-income countries. Since 2012, Gavi has supported Hib and hepB vaccines only as part of the pentavalent vaccine. With our support, the pentavalent vaccine is now available ...
